On the basis of these facts, the downregulation of ERα expression by TNF-α treatment may contribute to overcoming the resistance to chemotherapy in patients with ERα-positive breast cancer; however, the molecular mechanism underlying this phenomenon remains unclear. This evidence concerns the gene TNF and breast carcinoma.